Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 321

Results For "NDA"

3522 News Found

Algorithm to calculate number of years one lives with good health
Healthcare | October 12, 2021

Algorithm to calculate number of years one lives with good health

In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


Intas launches the world's first SB-100mg Itraconazole
Drug Approval | October 12, 2021

Intas launches the world's first SB-100mg Itraconazole

Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption


Boehringer Ingelheim launches University of Medicine Excellence
News | October 12, 2021

Boehringer Ingelheim launches University of Medicine Excellence

Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs


Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials
Biotech | October 11, 2021

Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials

VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials


IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation
Healthcare | October 11, 2021

IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation

Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels


Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir
News | October 11, 2021

Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir

If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


Cyprium Therapeutics and Sentynl, a Zydus subsidiary announce positive data for CUTX-101, CuHis
Biotech | October 09, 2021

Cyprium Therapeutics and Sentynl, a Zydus subsidiary announce positive data for CUTX-101, CuHis

The rolling submission to the U.S. FDA will begin in the fourth quarter of this year